Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

Diagnostic performance of guaiac-based fecal occult blood test in routine screening: state-wide analysis from Bavaria, Germany.

Brenner H, Hoffmeister M, Birkner B, Stock C.

Am J Gastroenterol. 2014 Mar;109(3):427-35. doi: 10.1038/ajg.2013.424. Epub 2013 Dec 17.

PMID:
24343548
2.

Men with negative results of guaiac-based fecal occult blood test have higher prevalences of colorectal neoplasms than women with positive results.

Brenner H, Hoffmeister M, Birkner B, Stock C.

Int J Cancer. 2014 Jun 15;134(12):2927-34. doi: 10.1002/ijc.28618. Epub 2013 Dec 11.

3.

Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1.

4.
5.

Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection.

Hundt S, Haug U, Brenner H.

Ann Intern Med. 2009 Feb 3;150(3):162-9.

PMID:
19189905
6.

Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test.

Denis B, Ruetsch M, Strentz P, Vogel JY, Guth F, Boyaval JM, Pagnon X, Ebelin JF, Gendre I, Perrin P.

Gut. 2007 Nov;56(11):1579-84. Epub 2007 Jul 6.

7.

Sex differences in performance of fecal occult blood testing.

Brenner H, Haug U, Hundt S.

Am J Gastroenterol. 2010 Nov;105(11):2457-64. doi: 10.1038/ajg.2010.301. Epub 2010 Aug 10.

PMID:
20700114
8.

Which adenomas are detected by fecal occult blood testing? A state-wide analysis from Bavaria, Germany.

Brenner H, Hoffmeister M, Birkner B, Stock C.

Int J Cancer. 2015 Apr 1;136(7):1672-9. doi: 10.1002/ijc.29148. Epub 2014 Sep 2.

9.

Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.

Tinmouth J, Lansdorp-Vogelaar I, Allison JE.

Gut. 2015 Aug;64(8):1327-37. doi: 10.1136/gutjnl-2014-308074. Epub 2015 Jun 3. Review.

PMID:
26041750
10.

Guaiac faecal occult blood test performance at initial and repeat screens in the English Bowel Cancer Screening Programme.

Kearns B, Whyte S, Chilcott J, Patnick J.

Br J Cancer. 2014 Oct 28;111(9):1734-41. doi: 10.1038/bjc.2014.469. Epub 2014 Sep 2.

11.

Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.

Dinh T, Ladabaum U, Alperin P, Caldwell C, Smith R, Levin TR.

Clin Gastroenterol Hepatol. 2013 Sep;11(9):1158-66. doi: 10.1016/j.cgh.2013.03.013. Epub 2013 Mar 28.

PMID:
23542330
12.

Comparison of the performance of guaiac-based and two immunochemical fecal occult blood tests for identifying advanced colorectal neoplasia in Taiwan.

Ou CH, Kuo FC, Hsu WH, Lu CY, Yu FJ, Kuo CH, Wang JY, Wu MT, Shiea J, Wu DC, Hu HM.

J Dig Dis. 2013 Sep;14(9):474-83. doi: 10.1111/1751-2980.12077.

PMID:
23701988
13.

Colorectal cancer screening by guaiac faecal occult blood test in France: Evaluation of the programme two years after launching.

Leuraud K, Jezewski-Serra D, Viguier J, Salines E.

Cancer Epidemiol. 2013 Dec;37(6):959-67. doi: 10.1016/j.canep.2013.07.008. Epub 2013 Sep 12.

PMID:
24035240
15.

Systematic review and bivariate/HSROC random-effect meta-analysis of immunochemical and guaiac-based fecal occult blood tests for colorectal cancer screening.

Launois R, Le Moine JG, Uzzan B, Fiestas Navarrete LI, Benamouzig R.

Eur J Gastroenterol Hepatol. 2014 Sep;26(9):978-89. doi: 10.1097/MEG.0000000000000160. Review.

PMID:
25072382
16.

Performance improvements of stool-based screening tests.

van Dam L, Kuipers EJ, van Leerdam ME.

Best Pract Res Clin Gastroenterol. 2010 Aug;24(4):479-92. doi: 10.1016/j.bpg.2010.03.009. Review.

PMID:
20833351
17.

Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.

Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, Pauly MP, Shlager L, Palitz AM, Zhao WK, Schwartz JS, Ransohoff DF, Selby JV.

J Natl Cancer Inst. 2007 Oct 3;99(19):1462-70. Epub 2007 Sep 25.

PMID:
17895475
18.
19.

Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening.

Park DI, Ryu S, Kim YH, Lee SH, Lee CK, Eun CS, Han DS.

Am J Gastroenterol. 2010 Sep;105(9):2017-25. doi: 10.1038/ajg.2010.179. Epub 2010 May 25.

PMID:
20502450
20.

Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.

van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E.

Gastroenterology. 2008 Jul;135(1):82-90. doi: 10.1053/j.gastro.2008.03.040. Epub 2008 Mar 25.

PMID:
18482589

Supplemental Content

Support Center